» Articles » PMID: 31787937

Alternative Sigma Factor B in Bovine Mastitis-Causing : Characterization of Its Role in Biofilm Formation, Resistance to Hydrogen Peroxide Stress, Regulon Members

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2019 Dec 3
PMID 31787937
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines treatments of the bacterial pathogen , namely, in the context of its being a major cause of subclinical bovine mastitis. Such infections caused by among dairy cows are difficult to detect and can easily become chronic, leading to reduced productivity and large losses for dairy manufacturers. In this study, the role of alternative sigma factor B (σ), which has been shown to be a global regulator for infections, was explored in a mastitis-causing strain, RF122. For comparison with the wild-type strain, a null (Δ) mutant was constructed and analyzed for its phenotypes and transcriptome. Our study found that σ is essential for biofilm formation as the Δ mutant strain produced significantly less biofilm than did the wild-type strain at 48 h. σ is involved in response to HO stress. However, σ plays a minor or no role in resistance to antiseptics (e.g., povidone-iodine and chlorhexidine), resistance to tested antibiotics, hemolysin activity, and invasion ability. RNA sequencing identified 225 σ-dependent genes, of which 171 are positively regulated and 54 are negatively regulated. The identified genes are involved in stress response, pathogenesis, and metabolic mechanisms. Quantitative TaqMan RT-PCR was performed to verify the RNA sequencing results; i.e., σ is a positive regulator for , and expressions. In the RF122 strain, σ plays a role in biofilm formation, general stress response (e.g., HO), and regulation of virulence factors and virulence-associated genes.

Citing Articles

Functional and Proteomic Dissection of the Contributions of CodY, SigB and the Hibernation Promoting Factor HPF to Interactions of USA300 with Human Lung Epithelial Cells.

Li X, Busch L, Piersma S, Wang M, Liu L, Salazar M J Proteome Res. 2024; 23(10):4742-4760.

PMID: 39302699 PMC: 11459534. DOI: 10.1021/acs.jproteome.4c00724.


Nanostructured N/S doped carbon dots/mesoporous silica nanoparticles and PVA composite hydrogel fabrication for anti-microbial and anti-biofilm application.

Pongchaikul P, Hajidariyor T, Khetlai N, Yu Y, Arjfuk P, Khemthong P Int J Pharm X. 2023; 6:100209.

PMID: 37711848 PMC: 10498006. DOI: 10.1016/j.ijpx.2023.100209.


Insight of Melatonin: The Potential of Melatonin to Treat Bacteria-Induced Mastitis.

Li H, Sun P Antioxidants (Basel). 2022; 11(6).

PMID: 35740004 PMC: 9219804. DOI: 10.3390/antiox11061107.


Advanced Glycation End Products Enhance Biofilm Formation by Promoting Extracellular DNA Release Through Upregulation in .

Xie X, Liu X, Li Y, Luo L, Yuan W, Chen B Front Microbiol. 2020; 11:1479.

PMID: 32765439 PMC: 7381169. DOI: 10.3389/fmicb.2020.01479.

References
1.
Lauderdale K, Boles B, Cheung A, Horswill A . Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun. 2009; 77(4):1623-35. PMC: 2663138. DOI: 10.1128/IAI.01036-08. View

2.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

3.
Palma M, Cheung A . sigma(B) activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth. Infect Immun. 2001; 69(12):7858-65. PMC: 98882. DOI: 10.1128/IAI.69.12.7858-7865.2001. View

4.
Pieterse R, Todorov S . Bacteriocins - exploring alternatives to antibiotics in mastitis treatment. Braz J Microbiol. 2013; 41(3):542-62. PMC: 3768644. DOI: 10.1590/S1517-83822010000300003. View

5.
Gruet P, Maincent P, Berthelot X, Kaltsatos V . Bovine mastitis and intramammary drug delivery: review and perspectives. Adv Drug Deliv Rev. 2001; 50(3):245-59. DOI: 10.1016/s0169-409x(01)00160-0. View